Effects of testosterone-augmented multimodal exercise intervention in spinal cord injury: a randomized controlled trial
CONTEXT: Spinal cord injury (SCI) leads to profound muscle atrophy, aerobic deconditioning, and metabolic dysfunction. Exercise-based interventions alone produce modest benefits. Whether testosterone can augment physiologic responses to exercise in this population remains untested. OBJECTIVE: To evaluate efficacy and safety of home-based intervention combining functional electrical stimulation-assisted leg cycling (FES-LC), arm ergometry (AE) and testosterone compared with FES-LC, AE plus placebo in adults with SCI. METHODS: This randomized, placebo-controlled, double-blind trial enrolled 84 adults (76 males and 8 females) aged 19-70 years with SCI (neurologic levels C4-T12; AIS grades A-D). Participants were randomized to multimodality intervention (home-based FES-LC, AE and intramuscular testosterone undecanoate) (n=38) or control intervention (FES-LC, AE plus placebo) (n=46) for 16 weeks. The primary outcome was change in aerobic capacity (peak VO2) during AE cardiopulmonary exercise testing. Secondary outcomes included lean mass, hemoglobin, cardiometabolic markers and safety. RESULTS: Mean (SD) age was 44 (13) yrs and time since injury was 13.9 (13) years). Between-group changes in peak VO2 were not statistically significant. Within-group improvements were larger in multimodality (∼19% increase; 0.10 L/min; 95% CI, 0.02-0.18 L/min) compared to controls (∼6% increase; 0.06 L/min; 95% CI, -0.01-0.13). The multimodality group gained significantly more lean mass (whole-body:1.84 kg, 95% CI: 0.52-3.16, P =.007; lower extremity 0.92 kg, 95% CI: 0.38-1.45, P =.001), and anemia was corrected in a greater proportion of participants. Adverse event rates were similar between groups. CONCLUSIONS: A home-based multimodality intervention combining FES-LC, AE, and testosterone was safe and associated with greater improvements in lean mass and hemoglobin. Although between-group differences in aerobic capacity were not statistically significant, greater within-group increases were observed in the multimodality group. These findings may inform future studies of testosterone-augmented exercise interventions for individuals living with SCI.
Authors
- Rodrigo J. Valderrábano (ORCID: https://orcid.org/0000-0002-4910-3997)
- Ross Zafonte (ORCID: https://orcid.org/0000-0002-1050-796X)
- Karol M. Pencina (ORCID: https://orcid.org/0000-0003-1824-7047)
- Kieran F. Reid (ORCID: https://orcid.org/0000-0001-9652-5319)
- Muni Ramanna GariSubhosh Chandra (ORCID: https://orcid.org/0000-0003-2706-2167)
- Thomas W. Storer (ORCID: https://orcid.org/0000-0002-5974-9791)
- Shalender Bhasin M. D (ORCID: https://orcid.org/0000-0002-3982-6200)
- Nicole Bajdek
- Sarah Everhart Skeels
- Catherine Ghattas
- Connor Gavin
- Nancy K. Latham (ORCID: https://orcid.org/0000-0002-8516-0016)
- Yili Valentine Shang
- Lauren Lemay
- Yashi Singh
- Alexander P Lin
- Eric M Bracken
Institutions
- Brigham and Women's Hospital (US)
- University of Missouri (US)
Publication Details
- Journal
- The Journal of Clinical Endocrinology & Metabolism
- Published
- 2026-04-15
- DOI
- https://doi.org/10.1210/clinem/dgag173
- Primary Topic
- Spinal Cord Injury Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Harvard Catalyst
- National Institutes of Health
- Eunice Kennedy Shriver National Institute of Child Health and Human Development